{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T20:52:28Z","timestamp":1783975948620,"version":"3.55.0"},"reference-count":42,"publisher":"The Journal of Rheumatology","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Rheumatol"],"accepted":{"date-parts":[[2025,11,24]]},"published-print":{"date-parts":[[2026,5]]},"abstract":"<jats:p>Hydroxychloroquine (HCQ) is a pharmacological agent in the management of various rheumatological disorders, including systemic lupus erythematosus and rheumatoid arthritis. Its therapeutic effects are attributed to its immunomodulatory and antimicrobial properties, and it is widely used due to its efficacy, relatively low cost, and generally favorable safety profile. Despite its well-established clinical utility, chronic use of HCQ is associated with serious ocular side effects. This review covers the history, pharmacokinetics, and ocular safety profile of HCQ, with a focus on the risk, diagnosis, and screening for ocular toxicity. Retinopathy, the most significant adverse ocular side effect, may lead to irreversible vision loss if not promptly detected.<\/jats:p>","DOI":"10.3899\/jrheum.2025-0127","type":"journal-article","created":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T13:20:13Z","timestamp":1765804813000},"page":"478-483","source":"Crossref","is-referenced-by-count":1,"title":["Hydroxychloroquine Ocular Toxicity: A Comprehensive Review"],"prefix":"10.3899","volume":"53","author":[{"given":"Marisa","family":"Sit","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan H.","family":"Mason","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander J.","family":"Kaplan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2262","published-online":{"date-parts":[[2025,12,15]]},"reference":[{"key":"2026050105301089000_53.5.478.1","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/j.1365-4362.1982.tb03155.x","article-title":"Anti-malarials in dermatology","volume":"21","author":"Isaacson","year":"1982","journal-title":"Int J Dermatol"},{"key":"2026050105301089000_53.5.478.2","doi-asserted-by":"publisher","DOI":"10.1177\/096120339600500102"},{"key":"2026050105301089000_53.5.478.3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(51)91643-1"},{"key":"2026050105301089000_53.5.478.4","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0140-6736(53)90138-X","article-title":"Lupus erythematosus treated with chloroquine","volume":"265","author":"Shee","year":"1953","journal-title":"Lancet"},{"key":"2026050105301089000_53.5.478.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2007.05.015"},{"key":"2026050105301089000_53.5.478.6","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1021\/ja01205a036","article-title":"Some 7-substituted 4-aminoquinoline derivatives","volume":"68","author":"Surrey","year":"1946","journal-title":"J Am Chem Soc"},{"key":"2026050105301089000_53.5.478.7","unstructured":"Wallace DJ. UpToDate. Antimalarial drugs in the treatment of rheumatic disease; 2024. [Internet. Accessed November 26, 2025.] Available from: https:\/\/www.uptodate.com\/contents\/antimalarial-drugs-in-the-treatment-of-rheumatic-disease"},{"key":"2026050105301089000_53.5.478.8","unstructured":"Singal AK , Anderson KE. Porphyria cutanea tarda and hepatoerythropoietic porphyria: management and prognosis; 2024. [Internet. Accessed November 26, 2025.] Available from: https:\/\/www.uptodate.com\/contents\/porphyria-cutanea-tarda-and-hepatoerythropoietic-porphyria-pathogenesis-clinical-manifestations-and-diagnosis"},{"key":"2026050105301089000_53.5.478.9","first-page":"1","article-title":"Diagnosis and management of Q fever \u2013 United States, 2013: recommendations from CDC and the Q fever working group","volume":"62","author":"Anderson","year":"2013","journal-title":"MMWR Recomm Rep"},{"key":"2026050105301089000_53.5.478.10","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1989.tb03439.x"},{"key":"2026050105301089000_53.5.478.11","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-020-0372-x"},{"key":"2026050105301089000_53.5.478.12","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s10787-015-0239-y","article-title":"Therapy and pharmacological properties of hydroxychloroquine and chloroquine in treatment of systemic lupus erythematosus, rheumatoid arthritis and related diseases","volume":"23","author":"Rainsford","year":"2015","journal-title":"Inflammopharmacol"},{"key":"2026050105301089000_53.5.478.13","unstructured":"Concordia Pharmaceuticals . Plaquenil, hydroxychloroquine sulfate tablets, USP. 2015. U.S. Food and Drug Administration. [Internet. Accessed November 26, 2025.] Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2019\/009768Orig1s051lbl.pdf"},{"key":"2026050105301089000_53.5.478.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2016.01.058"},{"key":"2026050105301089000_53.5.478.15","doi-asserted-by":"crossref","unstructured":"Browning DJ. Pharmacology of chloroquine and hydroxychloroquine. In: Hydroxychloroquine and chloroquine retinopathy. New York: Springer; 2014:35-63.","DOI":"10.1007\/978-1-4939-0597-3_2"},{"key":"2026050105301089000_53.5.478.16","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.151094"},{"key":"2026050105301089000_53.5.478.17","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1996.tb00190.x"},{"key":"2026050105301089000_53.5.478.18","doi-asserted-by":"publisher","DOI":"10.1177\/0961203313476361"},{"key":"2026050105301089000_53.5.478.19","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/imj.12100","article-title":"A cross-sectional study of hydroxychloroquine concentrations and effects in people with systemic lupus erythematosus","volume":"43","author":"Carmichael","year":"2013","journal-title":"Intern Med J"},{"key":"2026050105301089000_53.5.478.20","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-015-8469-8"},{"key":"2026050105301089000_53.5.478.21","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1002\/art.39194","article-title":"Determinants of hydroxychloroquine blood concentration variations in systemic lupus erythematosus","volume":"67","author":"Jallouli","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"2026050105301089000_53.5.478.22","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/0002-9343(83)91269-X","article-title":"Dose refinements in long-term therapy of rheumatoid arthritis with antimalarials","volume":"75","author":"Mackenzie","year":"1983","journal-title":"Am J Med"},{"key":"2026050105301089000_53.5.478.23","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1001\/jamaophthalmol.2014.3459","article-title":"The risk of toxic retinopathy in patients on long-term hydroxychloroquine therapy","volume":"132","author":"Melles","year":"2014","journal-title":"JAMA Ophthalmol"},{"key":"2026050105301089000_53.5.478.24","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1016\/0006-2952(67)90233-X","article-title":"Metabolism of chloroquine-3-14C in the rhesus monkey","volume":"16","author":"McChesney","year":"1967","journal-title":"Biochem Pharmacol"},{"key":"2026050105301089000_53.5.478.25","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(83)91265-2"},{"key":"2026050105301089000_53.5.478.26","doi-asserted-by":"publisher","DOI":"10.1136\/lupus-2022-000789"},{"key":"2026050105301089000_53.5.478.27","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2015.07.012"},{"key":"2026050105301089000_53.5.478.28","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.jcjo.2015.08.003","article-title":"Retinal toxicity of high-dose hydroxychloroquine in patients with chronic graft-versus-host disease","volume":"50","author":"Navajas","year":"2015","journal-title":"Can J Ophthalmol"},{"key":"2026050105301089000_53.5.478.29","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2005.04.042"},{"key":"2026050105301089000_53.5.478.30","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9394(01)00838-8"},{"key":"2026050105301089000_53.5.478.31","doi-asserted-by":"publisher","DOI":"10.1186\/s12886-015-0008-0"},{"key":"2026050105301089000_53.5.478.32","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1002\/art.39402","article-title":"Association of polymorphisms of cytochrome P450 2D6 with blood hydroxychloroquine levels in patients with systemic lupus erythematosus","volume":"68","author":"Lee","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"2026050105301089000_53.5.478.33","first-page":"294","article-title":"Ocular toxicity of hydroxychloroquine","volume":"12","author":"Yam","year":"2006","journal-title":"Hong Kong Med J"},{"key":"2026050105301089000_53.5.478.34","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1002\/art.41683","article-title":"American College of Rheumatology, American Academy of Dermatology, Rheumatologic dermatology society, and American Academy of Ophthalmology 2020 joint statement on hydroxychloroquine use with respect to retinal toxicity","volume":"73","author":"Rosenbaum","year":"2021","journal-title":"Arthritis Rheumatol"},{"key":"2026050105301089000_53.5.478.35","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1001\/jamaophthalmol.2016.0155","article-title":"Analysis of inner and outer retinal thickness in patients using hydroxychloroquine prior to development of retinopathy","volume":"134","author":"de Sisternes","year":"2016","journal-title":"JAMA Ophthalmol"},{"key":"2026050105301089000_53.5.478.36","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ophtha.2014.07.018","article-title":"Pericentral retinopathy and racial differences in hydroxychloroquine toxicity","volume":"122","author":"Melles","year":"2015","journal-title":"Ophthalmology"},{"key":"2026050105301089000_53.5.478.37","doi-asserted-by":"publisher","DOI":"10.1007\/s10633-006-9006-0"},{"key":"2026050105301089000_53.5.478.38","doi-asserted-by":"publisher","DOI":"10.1001\/archophthalmol.2011.371"},{"key":"2026050105301089000_53.5.478.39","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.05-1290"},{"key":"2026050105301089000_53.5.478.40","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.3390\/diagnostics13101752","article-title":"Review of retinal imaging modalities for hydroxychloroquine retinopathy","volume":"13","author":"Cheong","year":"2023","journal-title":"Diagnostics"},{"key":"2026050105301089000_53.5.478.41","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.3390\/diagnostics13142373","article-title":"Detection of hydroxychloroquine retinopathy via hyperspectral and deep learning through ophthalmoscope images","volume":"13","author":"Fan","year":"2023","journal-title":"Diagnostics"},{"key":"2026050105301089000_53.5.478.42","doi-asserted-by":"crossref","first-page":"448","DOI":"10.3390\/jpm14050448","article-title":"Automated evaluation of ellipsoid zone at-risk burden for detection of hydroxychloroquine retinopathy","volume":"14","author":"Talcott","year":"2024","journal-title":"J Pers Med"}],"container-title":["The Journal of Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.3899\/jrheum.2025-0127","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T12:30:22Z","timestamp":1777638622000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jrheum.org\/lookup\/doi\/10.3899\/jrheum.2025-0127"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,15]]},"references-count":42,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,5,1]]},"published-print":{"date-parts":[[2026,5]]}},"alternative-id":["10.3899\/jrheum.2025-0127"],"URL":"https:\/\/doi.org\/10.3899\/jrheum.2025-0127","relation":{},"ISSN":["0315-162X","1499-2752"],"issn-type":[{"value":"0315-162X","type":"print"},{"value":"1499-2752","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,15]]}}}